Schouten T J, De Abreu R A, Schretlen E D, van Leeuwen M B, van Baal J M, de Vaan G A
J Cancer Res Clin Oncol. 1985;110(2):115-8. doi: 10.1007/BF00402722.
6-Thioguanine (6TG) is poorly absorbed after oral administration. Bolus injections of 6TG result in high peak concentrations with relatively short-lived plasma concentrations. In vitro studies have shown the importance of prolonged exposure to 6TG. Therefore we administered 6TG by infusion at a dose rate of 2 mg/h over 2 h. In three goats we determined the plasma concentration-time curves of 6TG and its riboside (6TGR). A steady state was reached for 6TG and was almost reached for 6TGR within the 2 h of infusion. In one experiment we obtained several samples of CSF and observed good penetration of 6TG and 6TGR into CSF. Urinary excretion of 6TG and 6TGR was also quantitated. The amount of drug and metabolite excreted later than 4 h after the end of the infusion was negligible. By infusing 6TG, the problems of both erratic absorption after oral administration and acute renal toxicity after bolus injection, can be averted. In our opinion prolonged infusions of 6TG may be of advantage in humans suffering from actively proliferating malignant diseases, and thus should be studied.
6-硫鸟嘌呤(6TG)口服后吸收不佳。静脉推注6TG会导致血药浓度峰值较高,但血浆浓度维持时间相对较短。体外研究表明延长6TG暴露时间的重要性。因此,我们以2mg/h的剂量速率持续输注6TG 2小时。在三只山羊身上,我们测定了6TG及其核苷(6TGR)的血药浓度-时间曲线。在输注的2小时内,6TG达到了稳态,6TGR也几乎达到了稳态。在一项实验中,我们采集了多个脑脊液样本,发现6TG和6TGR能很好地穿透进入脑脊液。我们还对6TG和6TGR的尿排泄量进行了定量分析。输注结束4小时后排出的药物和代谢物量可忽略不计。通过输注6TG,可以避免口服给药后吸收不稳定和静脉推注后急性肾毒性的问题。我们认为,对于患有活跃增殖性恶性疾病的患者,延长6TG输注时间可能有益,因此值得进一步研究。